Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 2010; Volume 332,Issue 2

HIGHLIGHTED PAPER

  • You have access
    CYP2C9*1B Promoter Polymorphisms Affect Phenytoin Auto-Induction of Clearance and Maintenance Dose
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 335;

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Antitumorigenic Effects of Cannabinoids beyond Apoptosis
    Nadine Freimuth, Robert Ramer and Burkhard Hinz
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 336-344; DOI: https://doi.org/10.1124/jpet.109.157735

BEHAVIORAL PHARMACOLOGY

  • You have access
    Reinforcing Effects of σ-Receptor Agonists in Rats Trained to Self-Administer Cocaine
    Takato Hiranita, Paul L. Soto, Gianluigi Tanda and Jonathan L. Katz
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 515-524; DOI: https://doi.org/10.1124/jpet.109.159236
  • You have access
    Pharmacologic Antagonism of the Oral Aversive Taste-Directed Response to Capsaicin in a Mouse Brief Access Taste Aversion Assay
    Daniel J. Long, Heather R. Devantier, Francis X. Brennan, Robert W. Bryant, F. Raymond Salemme and R. Kyle Palmer
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 525-530; DOI: https://doi.org/10.1124/jpet.109.155416
  • You have access
    Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist
    S. Snigdha, M. Horiguchi, M. Huang, Z. Li, M. Shahid, J. C. Neill and H. Y. Meltzer
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 622-631; DOI: https://doi.org/10.1124/jpet.109.156349
  • You have access
    Acute Effects of Cocaine on Movement-Related Firing of Dorsolateral Striatal Neurons Depend on Predrug Firing Rate and Dose
    Anthony P. Pawlak, Chris C. Tang, Cathy Pederson, Martin B. Wolske and Mark O. West
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 667-683; DOI: https://doi.org/10.1124/jpet.109.158253

CARDIOVASCULAR

  • You have access
    TVP1022 Protects Neonatal Rat Ventricular Myocytes against Doxorubicin-Induced Functional Derangements
    Alexandra Berdichevski, Gideon Meiry, Felix Milman, Irena Reiter, Oshra Sedan, Sivan Eliyahu, Heather S. Duffy, Moussa B. Youdim and Ofer Binah
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 413-420; DOI: https://doi.org/10.1124/jpet.109.161158
  • You have access
    Inhibition of Dystrophin Breakdown and Endothelial Nitric-Oxide Synthase Uncoupling Accounts for Cytoprotection by 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e) in Left Ventricular Hypertrophied Mice
    Feng Han, Ying-Mei Lu, Hideyuki Hasegawa, Hiroshi Kanai, Erika Hachimura, Yasufumi Shirasaki and Kohji Fukunaga
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 421-428; DOI: https://doi.org/10.1124/jpet.109.161646
  • You have access
    Liposome-Encapsulated Hemoglobin Ameliorates Ischemic Stroke in Nonhuman Primates: An Acute Study
    Akira T. Kawaguchi, Munetaka Haida, Mariko Yamano, Dai Fukumoto, Yoshitaka Ogata and Hideo Tsukada
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 429-436; DOI: https://doi.org/10.1124/jpet.109.160051
  • You have access
    Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats
    Virak Mam, Alain F. Tanbe, Sally H. Vitali, Elena Arons, Helen A. Christou and Raouf A. Khalil
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 455-462; DOI: https://doi.org/10.1124/jpet.109.160119
  • You have access
    Cardamonin Is a Bifunctional Vasodilator that Inhibits Cav1.2 Current and Stimulates KCa1.1 Current in Rat Tail Artery Myocytes
    Fabio Fusi, Maurizio Cavalli, Dulcie Mulholland, Neil Crouch, Phil Coombes, Gill Dawson, Sergio Bova, Giampietro Sgaragli and Simona Saponara
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 531-540; DOI: https://doi.org/10.1124/jpet.109.161265
  • You have access
    Endothelium-Dependent Vasodilator Effects of Peroxisome Proliferator-Activated Receptor β Agonists via the Phosphatidyl-Inositol-3 Kinase-Akt Pathway
    Rosario Jiménez, Manuel Sánchez, María José Zarzuelo, Miguel Romero, Ana María Quintela, Rocío López-Sepúlveda, Pilar Galindo, Manuel Gómez-Guzmán, Jose Manuel Haro, Antonio Zarzuelo, Francisco Pérez-Vizcaíno and Juan Duarte
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 554-561; DOI: https://doi.org/10.1124/jpet.109.159806

CELLULAR AND MOLECULAR

  • You have access
    Identification and Analysis of Two Splice Variants of Human G2A Generated by Alternative Splicing
    Ai Ogawa, Hideru Obinata, Tomoyasu Hattori, Mikiko Kishi, Kazuaki Tatei, Osamu Ishikawa and Takashi Izumi
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 469-478; DOI: https://doi.org/10.1124/jpet.109.158758
  • You have access
    5-Hydroxytryptamine Receptor Stimulation of Mitochondrial Biogenesis
    Kyle A. Rasbach, Jason A. Funk, Tamilselvan Jayavelu, Peter T. Green and Rick G. Schnellmann
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 632-639; DOI: https://doi.org/10.1124/jpet.109.159947
  • You have access
    The D5 Dopamine Receptor Mediates Large-Conductance, Calcium- and Voltage-Activated Potassium Channel Activation in Human Coronary Artery Smooth Muscle Cells
    Aruna Natarajan, Guichun Han, Shi-you Chen, Peiying Yu, Richard White and Pedro Jose
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 640-649; DOI: https://doi.org/10.1124/jpet.109.159871
  • You have access
    Putative Transmembrane Domain 12 of the Human Organic Anion Transporter hOAT1 Determines Transporter Stability and Maturation Efficiency
    Mei Hong, Shanshan Li, Fanfan Zhou, Paul E. Thomas and Guofeng You
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 650-658; DOI: https://doi.org/10.1124/jpet.109.160515

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Differential Pharmacodynamic Effects of Paclitaxel Formulations in an Intracranial Rat Brain Tumor Model
    Rong Zhou, Richard V. Mazurchuk, Judith H. Tamburlin, John M. Harrold, Donald E. Mager and Robert M. Straubinger
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 479-488; DOI: https://doi.org/10.1124/jpet.109.160044
  • You have access
    Dysopsonin Activity of Serum DNA-Binding Proteins Favorable for Gene Delivery
    Feng Liu, Amber Frick, Xing Yuan and Leaf Huang
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 500-504; DOI: https://doi.org/10.1124/jpet.109.159541

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Influence of Cyclooxygenase Inhibitors on the Function of the Prostaglandin Transporter Organic Anion-Transporting Polypeptide 2A1 Expressed in Human Gastroduodenal Mucosa
    Kathrin Mandery, Krystyna Bujok, Ingrid Schmidt, Thomas Wex, Gerhard Treiber, Peter Malfertheiner, Tilman T. Rau, Kerstin U. Amann, Kay Brune, Martin F. Fromm and Hartmut Glaeser
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 345-351; DOI: https://doi.org/10.1124/jpet.109.154518
  • You have access
    Mechanistic Insight from In Silico Pharmacokinetic Experiments: Roles of P-glycoprotein, Cyp3A4 Enzymes, and Microenvironments
    Tai Ning Lam and C. Anthony Hunt
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 398-412; DOI: https://doi.org/10.1124/jpet.109.160739
  • You have access
    Functional Characterization of Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) in the Basolateral Efflux of Glucuronide Conjugates in the Mouse Small Intestine
    Yoshiaki Kitamura, Hiroyuki Kusuhara and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 659-666; DOI: https://doi.org/10.1124/jpet.109.156943
  • You have access
    Significance of Chymase-Dependent Matrix Metalloproteinase-9 Activation on Indomethacin-Induced Small Intestinal Damages in Rats
    Kazuki Kakimoto, Shinji Takai, Mitsuyuki Murano, Kumi Ishida, Yukiko Yoda, Takuya Inoue, Denan Jin, Eiji Umegaki and Kazuhide Higuchi
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 684-689; DOI: https://doi.org/10.1124/jpet.109.162933

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    Inhibition of Delayed-Type Hypersensitivity by Cucurbitacin R through the Curbing of Lymphocyte Proliferation and Cytokine Expression by Means of Nuclear Factor AT Translocation to the Nucleus
    José M. Escandell, María-Carmen Recio, Rosa M. Giner, Salvador Máñez, Miguel Cerdá-Nicolás, Irmgard Merfort and José-Luis Ríos
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 352-363; DOI: https://doi.org/10.1124/jpet.109.159327
  • You have access
    Lipoxin A4 Reduces Lipopolysaccharide-Induced Inflammation in Macrophages and Intestinal Epithelial Cells through Inhibition of Nuclear Factor-κB Activation
    Izumi Kure, Shin Nishiumi, Yosuke Nishitani, Takeshi Tanoue, Tsukasa Ishida, Masashi Mizuno, Tsuyoshi Fujita, Hiromu Kutsumi, Makoto Arita, Takeshi Azuma and Masaru Yoshida
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 541-548; DOI: https://doi.org/10.1124/jpet.109.159046

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

  • You have access
    Quantitative Prediction and Clinical Observation of a CYP3A Inhibitor-Based Drug-Drug Interactions with MLN3897, a Potent C-C Chemokine Receptor-1 Antagonist
    Chuang Lu, Suresh K. Balani, Mark G. Qian, Shimoga R. Prakash, Patricia S. Ducray and Lisa L. von Moltke
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 562-568; DOI: https://doi.org/10.1124/jpet.109.161893
  • You have access
    Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse Model
    Xin Zhou, Xiaoliang Zhuo, Fang Xie, Kerri Kluetzman, Yue-Zhong Shu, W. Griffith Humphreys and Xinxin Ding
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 578-587; DOI: https://doi.org/10.1124/jpet.109.162610
  • You have access
    CYP2C9*1B Promoter Polymorphisms, in Linkage with CYP2C19*2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose
    Amarjit S. Chaudhry, Thomas J. Urban, Jatinder K. Lamba, Angela K. Birnbaum, Rory P. Remmel, Murali Subramanian, Stephen Strom, Joyce H. You, Dalia Kasperaviciute, Claudia B. Catarino, Rodney A. Radtke, Sanjay M. Sisodiya, David B. Goldstein and Erin G. Schuetz
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 599-611; DOI: https://doi.org/10.1124/jpet.109.161026

NEUROPHARMACOLOGY

  • You have access
    Neurotransmitters and Energy Metabolites in Amyloid-Bearing APPSWE×PSEN1dE9 Mouse Brain
    Joachim Hartmann, Cornelia Kiewert and Jochen Klein
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 364-370; DOI: https://doi.org/10.1124/jpet.109.161091
  • You have access
    Nicotine Exacerbates Brain Edema during In Vitro and In Vivo Focal Ischemic Conditions
    Jennifer R. Paulson, Tianzhi Yang, Pradeep K. Selvaraj, Alexander Mdzinarishvili, Cornelis J. Van der Schyf, Jochen Klein, Ulrich Bickel and Thomas J. Abbruscato
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 371-379; DOI: https://doi.org/10.1124/jpet.109.157776
  • You have access
    A Novel Calpain Inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic Acid 5-Methoxy-3-oxapentyl Ester (SNJ-1945), Reduces Murine Retinal Cell Death In Vitro and In Vivo
    Masamitsu Shimazawa, Shinsuke Suemori, Yuta Inokuchi, Nozomu Matsunaga, Yoshimi Nakajima, Takayuki Oka, Tetsuya Yamamoto and Hideaki Hara
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 380-387; DOI: https://doi.org/10.1124/jpet.109.156612
  • You have access
    Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB
    Johann Meunier and Teruo Hayashi
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 388-397; DOI: https://doi.org/10.1124/jpet.109.160960
  • You have access
    Amoxapine Inhibits the Delayed Rectifier Outward K+ Current in Mouse Cortical Neurons via cAMP/Protein Kinase A Pathways
    Yan-Lin He, Xiao-Qin Zhan, Guang Yang, Ji Sun and Yan-Ai Mei
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 437-445; DOI: https://doi.org/10.1124/jpet.109.159160
  • You have access
    Multipotent Neurotrophin Antagonist Targets Brain-Derived Neurotrophic Factor and Nerve Growth Factor
    J. K. Eibl, S. A. Chapelsky and G. M. Ross
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 446-454; DOI: https://doi.org/10.1124/jpet.109.159079
  • You have access
    Brain-Derived Neurotrophic Factor Signaling Modulates Cocaine Induction of Reward-Associated Ultrasonic Vocalization in Rats
    Stacey N. Williams and Ashiwel S. Undieh
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 463-468; DOI: https://doi.org/10.1124/jpet.109.158535
  • You have access
    The Aminoglycosides Modulate the Acid-Sensing Ionic Channel Currents in Dorsal Root Ganglion Neurons from the Rat
    Aníbal Garza, Omar López-Ramírez, Rosario Vega and Enrique Soto
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 489-499; DOI: https://doi.org/10.1124/jpet.109.152884
  • You have access
    Imipramine, in Part through Tumor Necrosis Factor α Inhibition, Prevents Cognitive Decline and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease
    F. Chavant, J. Deguil, S. Pain, I. Ingrand, S. Milin, B. Fauconneau, M.-C. Pérault-Pochat and C. Lafay-Chebassier
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 505-514; DOI: https://doi.org/10.1124/jpet.109.162164
  • You have access
    Intrahypothalamic Injection of the HIV-1 Envelope Glycoprotein Induces Fever via Interaction with the Chemokine System
    Khalid Benamar, Saad Addou, Menachem Yondorf, Ellen B. Geller, Toby K. Eisenstein and Martin W. Adler
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 549-553; DOI: https://doi.org/10.1124/jpet.109.160309
  • You have access
    Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
    Nicholas A. Jones, Andrew J. Hill, Imogen Smith, Sarah A. Bevan, Claire M. Williams, Benjamin J. Whalley and Gary J. Stephens
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 569-577; DOI: https://doi.org/10.1124/jpet.109.159145
  • You have access
    Physiological Concentrations of Choline Activate Native α7-Containing Nicotinic Acetylcholine Receptors in the Presence of PNU-120596 [1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea]
    Alexander G. Gusev and Victor V. Uteshev
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 588-598; DOI: https://doi.org/10.1124/jpet.109.162099
  • You have access
    Lobelane Inhibits Methamphetamine-Evoked Dopamine Release via Inhibition of the Vesicular Monoamine Transporter-2
    Justin R. Nickell, Sairam Krishnamurthy, Seth Norrholm, Gabriela Deaciuc, Kiran B. Siripurapu, Guangrong Zheng, Peter A. Crooks and Linda P. Dwoskin
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 612-621; DOI: https://doi.org/10.1124/jpet.109.160275

Erratum

  • You have access
    Correction to “Evidence for Allosteric Interactions of Antagonist Binding to the Smoothened Receptor”
    Journal of Pharmacology and Experimental Therapeutics February 2010, 332 (2) 690;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 332 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 332, Issue 2
1 Feb 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • HIGHLIGHTED PAPER
  • PERSPECTIVES IN PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
  • METABOLISM, TRANSPORT, AND PHARMACOGENOMICS
  • NEUROPHARMACOLOGY
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics